Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X0IU
|
|||
| Former ID |
DIB007839
|
|||
| Drug Name |
LMB-2
|
|||
| Synonyms |
LMB-2a; AntiTac(Fv)-PE38; Immunotoxin (cancer), National Cancer Institute
Click to Show/Hide
|
|||
| Indication | Chronic lymphocytic leukaemia [ICD-11: 2A82.0; ICD-10: C83.0, C91.1] | Phase 2 | [1] | |
| Company |
National Cancer Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies. J Clin Oncol. 2000 Apr;18(8):1622-36. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.